Acreage Provides Update on Timing of Filing of Financial Statements for 2019
NEW YORK, May 13, 2020 (GLOBE NEWSWIRE) — Acreage Holdings, Inc. (“Acreage” or the “Company”) (CSE: ACRG.U) (OTCQX: ACRGF) (FSE: […]
MacroGenics Announces Preliminary Clinical Results from MGD013 and MGC018 to be Presented at the ASCO Annual Meeting
Rockville, MD, May 13, 2020 (GLOBE NEWSWIRE) —MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing […]
Osmotica Pharmaceuticals plc to Present at the 2020 RBC Capital Markets Global Healthcare Virtual Conference
BRIDGEWATER, N.J., May 13, 2020 (GLOBE NEWSWIRE) — Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“Osmotica” or the “Company”), a fully integrated […]
PDS Biotechnology Announces Publication at American Society of Clinical Oncology (ASCO) 2020
FLORHAM PARK, N.J., May 13, 2020 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel […]
TSX News -
Savaria Announces the Voting Results from Annual General Meeting of Shareholders
LAVAL, Quebec, May 13, 2020 (GLOBE NEWSWIRE) — Savaria Corporation (“Savaria”) (TSX: SIS) one of the global leaders in the […]
TSX News -
Western Provides Update for Annual General Meeting
VANCOUVER, British Columbia, May 13, 2020 (GLOBE NEWSWIRE) — Western Forest Products Inc. (TSX: WEF) (“Western” or the “Company”) announced […]
Vaccinex to Present Updated Results from CLASSICAL-Lung, Phase 1b/2 Study of Pepinemab (VX15/2503) in Combination with Avelumab (BAVENCIO®) in Non-Small Cell Lung Cancer at the American Society of Clinical Oncology (ASCO) 2020 Annual Meeting
ROCHESTER, N.Y., May 13, 2020 (GLOBE NEWSWIRE) — Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company pioneering a differentiated approach […]
TSX News -
IPL Plastics Inc. Announced Executive Management Changes
MONTREAL, May 13, 2020 (GLOBE NEWSWIRE) — IPL Plastics Inc. (“IPLP” or the “Company”) (TSX: IPLP) today announced that Chief […]
Iovance Biotherapeutics Announces Clinical Data Updates for Lifileucel in Advanced Melanoma
Median Duration of Response Not Reached at 17.0 Months of Median Study Follow Up in C-144-01 StudyOral Presentation to Include Additional […]
Immunomedics to Present New Trodelvy™ Data In Non-Breast Cancer Indications at the 2020 ASCO Virtual Meeting
MORRIS PLAINS, N.J., May 13, 2020 (GLOBE NEWSWIRE) — Immunomedics, Inc., (NASDAQ: IMMU) (“Immunomedics” or the “Company”), a leading biopharmaceutical […]
